The Virtus Zevenbergen Innovative Growth Stock Fund returned -2.74% (Class I) in the quarter, trailing the Russell 3000 Growth Index's 1.14% return. Read more here.

Exact Sciences accounts for an estimated $6 billion to $7 billion of Wisconsin's gross domestic product – as much as roughly ...

Abbott Laboratories (NYSE:ABT) is one of the Best Conservative Stocks to Buy Right Now. On March 23, the company announced ...

The John Hancock Small Cap Core Fund outperformed its benchmark in Q4 due to strong stock selection in industrials. Read the ...

Abbott closes $21B acquisition of Exact Sciences (EXAS) at $105/share. EXAS delisted from Nasdaq on March 23, 2026, becoming ...

The deal brings Exact Sciences' flagship screening test for colorectal cancer, Cologuard, under Abbott's umbrella.

Abbott (NYSE:ABT) announced today that it completed its acquisition of cancer diagnostics developer Exact Sciences.